The research paper focused on the effects of diallyl trisulfide (DATS) on hypoxia-induced gene and protein expressions and showed that targeting HIF-1α genes in BC can inhibit EMT and metastasis, especially under hypoxic conditions. This evidence concerns the gene HIF1A and breast cancer.